Wednesday, 14 October 2026European Markets

KPN KON And VIVENDI SE Have A High Dividend Yield And Return On Equity In The Communication Services Sector.

Loading stream...

(vianews) - kpn kon (kpn.as) is among this list of stock assets with the highest dividend rate and return on equity on the communication services sector.

financial asset price forward dividend yield return on equity
kpn kon (kpn.as) €3.40 4.52% 23.35%
vivendi se (viv.pa) €10.10 2.53% 2.81%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. kpn kon (kpn.as)

4.52% forward dividend yield and 23.35% return on equity

koninklijke kpn n.v. provides telecommunications and information technology (it) services in the netherlands. it operates through consumer; business; wholesale; and network, operations & it segments. the company offers fixed and mobile telephony, fixed and mobile broadband internet, and television services to retail and business consumers; infrastructure and network related it solutions to business customers; and wholesale network services to third parties. it also provides it services, including cloud, workspace, and cybersecurity services; interconnect traffic, visitor roaming, and digital products; and nl-ix, an interconnect exchange, as well as sells handsets, peripheral equipment, and software licenses. in addition, the company offers virus and malware scanners; anti-virus licenses; 1password, a password management tool; dnssec, a technology that prevents customers from being led to fake websites; kpn veilig netwerk thuis, a smart network security; censornet, which includes web security, cloud application security broker, email protection, and awareness training; supervision, which provides digital governance solutions for workspaces; and onemonitoring to ensure early detection of cyber incidents. further, it provides fiber networks; and it services for integrating healthcare systems and optimizing communication between healthcare providers. the company distributes its products and services under the kpn, xs4all, simyo, kpn security, kpn health, solcon, inspark, and kpn partner network brands. the company was formerly known as koninklijke ptt nederland nv and changed its name to koninklijke kpn n.v. in june 1998. koninklijke kpn n.v. was founded in 1881 and is headquartered in rotterdam, the netherlands.

earnings per share

as for profitability, kpn kon has a trailing twelve months eps of €0.21.

pe ratio

kpn kon has a trailing twelve months price to earnings ratio of 16.17. meaning, the purchaser of the share is investing €16.17 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.35%.

more news about kpn kon.

2. vivendi se (viv.pa)

2.53% forward dividend yield and 2.81% return on equity

vivendi se operates as an entertainment, media, and communication company in france, the rest of europe, the americas, asia/oceania, and africa. it operates through canal+ group, lagardère, havas, prisma media, gameloft, vivendi village, new initiatives, and generosity and solidarity segments. the canal+ group segment publishes and distributes premium and thematic pay-tv and free-to-air channels; and produces, sells, and distributes movies and tv series. the lagardère segment engages in the publishing, media, and travel retail activities. the havas segment includes communications disciplines, such as creativity, media expertise, and healthcare/wellness. the prisma media segment publishes french magazines and online videos. the gameloft segment engages in the creation and publishing of downloadable video games for various console-pc-mobile platforms, tablets, triple-play boxes, and smart tvs. the vivendi village segment provides ticketing services and live performances through olympia production, festival production, and venues. the new initiatives segment operates dailymotion, a video content aggregation and distribution platform, as well as develops ultra-high-speed internet service. the generosity and solidarity segment operates canalolympia; and vivendi foundation, a create joy solidarity program, which supports initial and professional training projects. the company was founded in 1853 and is headquartered in paris, france.

earnings per share

as for profitability, vivendi se has a trailing twelve months eps of €0.42.

pe ratio

vivendi se has a trailing twelve months price to earnings ratio of 24.05. meaning, the purchaser of the share is investing €24.05 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.81%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, vivendi se's stock is considered to be oversold (<=20).

more news about vivendi se.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com